Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Pérez-Jeldres, Manuel Álvarez-Lobos, Jesús Rivera–Nieves
Drugs (2021) Vol. 81, Iss. 9, pp. 985-1002
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease
Bram Verstockt, Stefania Vetrano, Azucena Salas, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 6, pp. 351-366
Closed Access | Times Cited: 87
New and Emerging Treatments for Inflammatory Bowel Disease
Masaaki Higashiyama, Ryota Hokari
Digestion (2022) Vol. 104, Iss. 1, pp. 74-81
Open Access | Times Cited: 71
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Rheumatoid arthritis: pathogenesis and therapeutic advances
Ying Gao, Yunkai Zhang, Xingguang Liu
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 31
Understanding the therapeutic toolkit for inflammatory bowel disease
Sophie Vieujean, Vipul Jairath, Laurent Peyrin‐Biroulet, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 4
The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives
Claudia Günther, Veit Rothhammer, Marisa Karow, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8870-8870
Open Access | Times Cited: 70
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
George Robinson, Inès Pineda‐Torra, Coziana Ciurtin, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 2
Open Access | Times Cited: 66
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
Alhaji H. Janneh, Besim Öğretmen
Cancers (2022) Vol. 14, Iss. 9, pp. 2183-2183
Open Access | Times Cited: 45
Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases
Nathalie Burg, Jane E. Salmon, Timothy Hla
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 6, pp. 335-351
Open Access | Times Cited: 40
Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases
Na Wang, Jingyi Li, Bo Zeng, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 818-818
Open Access | Times Cited: 24
Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review
Patricia K. Coyle, Mark S. Freedman, Bruce A. Cohen, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 4, pp. 842-855
Open Access | Times Cited: 14
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents
Anastasia Drakos, Tiago Torres, Ronald Vender
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 111-111
Open Access | Times Cited: 11
S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes
Dhaval Dixit, Victoria M. Hallisey, Ethan Y.S. Zhu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 4
Open Access | Times Cited: 10
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial
Bruce E Sands, Remo Panaccione, Geert R. DʼHaens, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 1
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
Huanyu Li, A.C.W. Pike, Yung-Ning Chang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells
Olivia Taylor, Nick DeGroff, Heithem M. El‐Hodiri, et al.
(2025)
Open Access | Times Cited: 1
Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod
Safura Pournajaf, Leila Dargahi, Mohammad Javan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine
Arianna Dal Buono, Roberto Gabbiadini, Ludovico Alfarone, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1735-1735
Open Access | Times Cited: 32
Evidence-based treatments for eosinophilic esophagitis: insights for the clinician
Sara Feo‐Ortega, Alfredo J. Lucendo
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 28
Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist
Archit Baskaran, Elena Grebenciucova, Thomas Shoemaker, et al.
Journal of Clinical Neurology (2023) Vol. 19, Iss. 3, pp. 217-217
Open Access | Times Cited: 17
Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
Caroline A. Lee, Stefan Schreiber, Brian Bressler, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 5, pp. 534-548
Open Access | Times Cited: 7
Superparamagnetic iron oxide nanoparticle regulates microbiota–gut–inner ear axis for hearing protection
Zhanhang Guo, Yunhao Wu, Bo Chen, et al.
National Science Review (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 6
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 6
Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
Jing Zhang, Yang Xiao, Jingyi Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
Romelia Barba, Bryan W. Ferrigno, Esli Medina Morales, et al.
The Turkish Journal of Gastroenterology (2023) Vol. 34, Iss. 2, pp. 89-100
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top